US Markets

Health Care Sector Update for 07/31/2020: ECOR,TLSA,GILD

Health care stocks were falling hard this afternoon, with the NYSE Health Care Index dropping 1.7% while the SPDR Health Care Select Sector ETF also was down 1.7%.

The Nasdaq Biotechnology index was sinking 2.7% in recent trade.

In company news, electroCore (ECOR) raced nearly 38% higher after the Us Food and Drug Administration granted an emergency use authorization for the company's gammaCore Sapphire CV vagus nerve stimulation therapy in COVID-19 patients with asthma-related dyspnea and reduced airflow. Initial distribution to hospitals and patients at home had been expected to begin Friday.

Tiziana Life Sciences (TLSA) was nearly 52% higher this afternoon, easing from a 146% gain earlier Friday, after the biotechnology company said it has filed a patent application for a nasal formulation of its Foralumab monoclonal antibody. The move follows phase I testing showing Foralumab had positive immunomodulatory effects in patients with COVID-19 by modulating the body's immune system to suppress the cytokine storm often associated with COVID-19.

Gilead Sciences (GILD) fell about 4.3% after the drugmaker reported non-GAAP Q2 net income of $1.11 per share on $5.14 billion in revenue, trailing the Capital IQ consensus expecting a $1.45 per share adjusted profit on $5.3 billion in revenue. Gilead shares also were pressured by reports an international panel of experts told the British Medical Journal the company's remdesivir prospective anti-viral drug needs more testing to determine its efficacy treating COVID-19.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ECOR TLSA GILD

Latest Markets Videos

MTNewswires

Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

Learn More